Pharmactive has introduced a new oral nutricosmetic ingredient named Kyoh®, which is designed to support hair growth and follicle function through a naturally derived botanical extract.
Kyoh® is a pure, standardized formulation sourced from rocket leaves, also known as Eruca sativa — a common salad green that has been traditionally used in South Asia as a hair tonic. The oral nutricosmetic ingredient works from within the body by leveraging a specific group of flavanol-rich compounds, trademarked as Erucosides®, which include quercetin, kaempferol, and isorhamnetin.
Preclinical laboratory studies have shown that the Kyoh® extract can influence several cellular mechanisms relevant to hair health, such as activating vascular endothelial growth factor to improve blood supply to the scalp, stimulating fibroblast growth factor 7 for keratin production, and upregulating the antioxidant regulator NRF2 to protect follicle cells from oxidative stress.
Image Credit: Pharmactive
What Makes This Trend Stand Out
- Oral Nutricosmetics Rise
- A shift toward ingestible beauty solutions that act systemically suggests new product categories merging nutrition and cosmetics to influence hair physiology from within.
- Botanical Bioactives Standardization
- The emergence of standardized plant extracts like Kyoh® indicates growing demand for reproducible, well-characterized botanicals that enable scalable formulation and regulatory clarity.
- Targeted Flavonoid Therapeutics
- Increasing focus on specific flavonols such as quercetin and kaempferol highlights potential for precision-targeted compounds that modulate growth factors and antioxidant pathways in follicle biology.
Sectors Adopting This
- Haircare and Scalp Health
- Formulations integrating oral and topical modalities could redefine treatment paradigms by addressing vascular, keratinogenic, and oxidative drivers of hair loss.
- Nutraceuticals and Supplements
- Standardized botanical extracts presenting measurable bioactive profiles open pathways for clinically positioned supplements targeting hair growth and follicle resilience.
- Clinical Cosmetic Research
- Preclinical mechanisms such as VEGF activation and NRF2 upregulation point to translational research opportunities that link molecular biomarkers with consumer-facing efficacy claims.
